PFA
ZBH icon

Pathway Financial Advisers’s Zimmer Biomet ZBH Stock Holding History

Pathway Financial Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-460
Closed -$45.3K – 366
2025
Q3 		$45.3K Buy
+460
New +$45.6K 0.01% 236
2025
Q1 		– Sell
-179
Closed -$18.8K – 430
2024
Q4 		$18.8K Sell
179
-886
-83% -$95.1K 0.01% 310
2024
Q3 		$115K Buy
1,065
+18
+2% +$1.96K 0.05% 140
2024
Q2 		$114K Buy
1,047
+2
+0.2% +$236 0.04% 178
2024
Q1 		$138K Buy
1,045
+521
+99% +$65.1K 0.05% 172
2023
Q4 		$63.8K Hold
524
– – 0.02% 211
2023
Q3 		$58.8K Buy
+524
New +$66.5K 0.02% 217
2023
Q1 		$16.2K Sell
125
-42
-25% -$5.27K 0.01% 328
2022
Q4 		$21.3K Buy
+167
New +$19.4K 0.01% 321

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Pathway Financial Advisers's ZBH Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 460 shares — an estimated $45.3K sold.

Pathway Financial Advisers first reported a position in ZBH in Q4 2022 and held it in 9 quarters. The position peaked at $138K in Q1 2024. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 460 Zimmer Biomet shares in Q4 2025, an estimated $45.3K.
  • Pathway Financial Advisers first reported a position in Zimmer Biomet in Q4 2022 and held it in 9 quarters.
  • Pathway Financial Advisers's Zimmer Biomet position peaked at $138K in Q1 2024.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.